TFS
MRNA icon

Thoroughbred Financial Services’s Moderna MRNA Stock Holding History

Thoroughbred Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,615
Closed -$270K – 613
2023
Q3 		$270K Buy
+2,615
New +$292K 0.03% 465
2019
Q3 		– Sell
-11,600
Closed -$170K – 240
2019
Q2 		$170K Buy
11,600
+500
+5% +$10.7K 0.06% 181
2019
Q1 		$226K Hold
11,100
– – 0.09% 204
2018
Q4 		$169K Buy
+11,100
New +$182K 0.08% 163

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thoroughbred Financial Services's MRNA Position: Q4 2023 in Review

Thoroughbred Financial Services sold out of Moderna (MRNA) in Q4 2023, closing a stake of 2,615 shares — an estimated $270K sold.

Thoroughbred Financial Services first reported a position in MRNA in Q4 2018 and held it in 4 quarters. The position peaked at $270K in Q3 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Thoroughbred Financial Services reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Thoroughbred Financial Services sold 2,615 Moderna shares in Q4 2023, an estimated $270K.
  • Thoroughbred Financial Services first reported a position in Moderna in Q4 2018 and held it in 4 quarters.
  • Thoroughbred Financial Services's Moderna position peaked at $270K in Q3 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Thoroughbred Financial Services's 13F filing for Q4 2023, filed 9 Feb 2024.